First Tracks Biotherapeutics (TRAX) Live Share Price, Invest From India

First Tracks Biotherapeutics Stock Performance

as on June 6, 2026 at 2:15 pm IST

Day's Low
Day's High
$16.63
Day's Price Range
$18.42
$16.60
-0.18%
Downside
10.96%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$16.60
100.00%
Downside
-100.00%
Upside

First Tracks Biotherapeutics share price movements today

Previous Close: $18.20
Open: $18.23
Volume: 916.2K
Day's Low - High: $16.63 - $18.42

First Tracks Biotherapeutics Historical Returns

1 Month Return: -14.11 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

First Tracks Biotherapeutics Stock Fundamentals & Key Indicators

Check First Tracks Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$534.6M

EPS (TTM)

-3.6003

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-48.92%

First Tracks Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of First Tracks Biotherapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
First Tracks Biotherapeutics	NA	$534.6M	NA	NA	0.00%	NA
Revolution Medicines Inc	BUY	$32.2B	410.63%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.1B	108.54%	73.51	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$108.7B	110.42%	25.45	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.9B	22.83%	15.11	29.65%	0.59%

Indian Investors' Interest in First Tracks Biotherapeutics Stock

Search interest for First Tracks Biotherapeutics Stock has increased by 2200% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 8, 2026 to June 7, 2026

Change:2200% versus previous 30 day period

First Tracks Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Mar 2026
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-51	-52
EBITDA	-50	-52
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-47	-50
Income Tax Expense	-	-
Net Income	-47	-50
Net Profit Margin	0.00%	0.00%

First Tracks Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024
Total Revenue	-	-
Gross Profit	-	-152
Operating Income	-118	-181
EBITDA	-116	-178
Interest Expense	-	-
Depreciation	2	2
Income Before Tax	-106	-163
Income Tax Expense	-	-
Net Income	-106	-163
Net Profit Margin	0.00%	0.00%

First Tracks Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026
Net Income	-50
Operating Cash Flow	-32
Investing Cash Flow	34
Financing Cash Flow	7
Change in Cash	10

First Tracks Biotherapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-163	-166
Operating Cash Flow	-125	-142
Investing Cash Flow	95	228
Financing Cash Flow	117	30
Change in Cash	87	115

Insights on First Tracks Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, TRAX stock has moved up by 4.0%

About First Tracks Biotherapeutics

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.

Organisation	First Tracks Biotherapeutics
Headquarters	10770 Wateridge Circle, San Diego, CA, United States, 92121
Industry	Biotechnology
CEO	Mr. Daniel R. Faga
E-voting on shares	Click here to vote

Key Management of First Tracks Biotherapeutics

Name	Title
Mr. Daniel R. Faga	CEO, President & Director
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D.	Chief Medical Officer
Mr. Ajim A. Tamboli C.F.A.	Chief Financial Officer
Mr. Benjamin Stone	Chief Business Officer
Mr. Eric J. Loumeau	Secretary

FAQs

What is First Tracks Biotherapeutics share price today?

First Tracks Biotherapeutics share price today is $16.6 as on June 6, 2026 at 8:45 am IST at the close of the market. First Tracks Biotherapeutics share today touched a day high of $18.42 and a low of $16.63.

What is the 52 week high and 52 week low for First Tracks Biotherapeutics share?

First Tracks Biotherapeutics share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. First Tracks Biotherapeutics stock price today i.e. June 6, 2026 at 8:45 am IST is closed at $16.6,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is First Tracks Biotherapeutics's market capitalisation today?

First Tracks Biotherapeutics market capitalisation is $0.00T as on June 6, 2026 at 8:45 am IST.

How to invest in First Tracks Biotherapeutics Stock (TRAX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for First Tracks Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in First Tracks Biotherapeutics Shares that will get you 0.0904 shares as per First Tracks Biotherapeutics share price of $16.6 per share as on June 6, 2026 at 8:45 am IST.

What is the minimum amount required to buy First Tracks Biotherapeutics Stock (TRAX) from India?

Indian investors can start investing in First Tracks Biotherapeutics (TRAX) shares with as little as ₹94.95 or $1 (as of June 7, 2026 at 8:59 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in First Tracks Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on June 7, 2026 at 8:59 am IST). Based on First Tracks Biotherapeutics share’s latest price of $16.6 as on June 6, 2026 at 8:45 am IST, you will get 0.6024 shares of First Tracks Biotherapeutics. Learn more about fractional shares .